News

Medical Dialogues23m
USFDA clears first blood test used in diagnosing Alzheimer's Disease
The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse ...
VOV.VN1h
HCM City revokes 70 medical device filings over violations
VOV.VN - The Ho Chi Minh City Department of Health has withdrawn 70 registrations for medical devices after uncovering ...
Sportschosun on MSN2h
Wells Bio selects the final government project in connection with the R&D Special Zone Promotion Project in 2025
Wells Bio Co., Ltd.'(CEO Lee Min-jeon), a subsidiary of the global in vitro diagnostic company 'Access Bio', announced on the ...
Medical Device Network4h
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...
Express Healthcare7h
FDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...